Fortress Biotech to Present at BioCentury’s 24th Annual Future Leaders in the Biotech Industry Conference
NEW YORK, March 30, 2017 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced that Lindsay …